Adler, A., Baraniak, A., Izdebski, R., Fiett, J., Gniadkowski, M., Hryniewicz, W., Salvia, A., Rossini, A., Goossens, H., Malhotra, S., Lerman, Y., Elenbogen, M. and Carmeli, Y. (2013) MOSAR WP5 & WP2 Study Groups: A Binational Cohort Study of Intestinal Colonization with Extended-Spectrum β-Lactamase-Producing Proteus mirabilis in Patients Admitted to Rehabilitation Centres. Clinical Microbiology and Infection, 19, E51-E8. http://dx.doi.org/10.1111/1469-0691.12072

has been cited by the following article:

• TITLE: Outcome of Early Neurological Rehabilitation Patients Colonized with Extended-Spectrum Beta-Lactamase (ESBL) Producing Bacteria

  AUTHORS: Jens D. Rollnik

  KEYWORDS: ESBL, Early Rehabilitation, Outcome, Neurology

  JOURNAL NAME: Open Journal of Therapy and Rehabilitation, Vol.3 No.1, January 15, 2015

  ABSTRACT: Colonization with multidrug-resistant germs, in particular methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum betalactamase producing bacteria (ESBL), is an emerging threat in early neurological rehabilitation. This study examined whether colonization with ESBL bacteria had deteriorating effects on neurological rehabilitation patients because of contact precautions (CP). Medical records have been carefully reviewed with respect to colonization with ESBL, outcome variables (functional independence), morbidity, and length of stay (LOS). 148/643 (23.0%) patients were ESBL positive on admission. ESBL carriers had a significantly longer LOS in early neurological rehabilitation (67.5 (42.0) vs. 25.8 (24.5), p